Trial Outcomes & Findings for Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation (NCT NCT01693367)

NCT ID: NCT01693367

Last Updated: 2020-08-13

Results Overview

To assess pain, stiffness, and physical function

Recruitment status

TERMINATED

Study phase

PHASE4

Target enrollment

5 participants

Primary outcome timeframe

12 months after surgery

Results posted on

2020-08-13

Participant Flow

The multicenter international study enrolled patients with distal femur fractures which were either stabilize with a Dynamic Locking Screw or a standard locking screw. The study was stopped due to implant breakages observed after planned implant removals in non-study patients treated with the DLS 5.0mm.

Five patients signed the informed consent form and were enrolled in the study before it was terminated. Three of the five patients were post-enrollment drop-outs and only two patients completed all study follow-up visits.

Participant milestones

Participant milestones
Measure
DLS 5.0 (Dynamic Locking Screws)
ORIF with DLS 5.0 (Dynamic Locking Screws) DLS 5.0 (Dynamic locking screws): Open reduction and internal fixation (ORIF) of the distal femur with a large fragment locking plate (LISS, LCP) and DLS 5.0
SLS (Standard Locking Screw)
ORIF with SLS (Standard locking screw) SLS (Standard locking screw): Open reduction and internal fixation (ORIF) of the distal femur with a large fragment locking plate (LISS, LCP)and SLS (Standard locking screw)
Overall Study
STARTED
2
3
Overall Study
COMPLETED
1
1
Overall Study
NOT COMPLETED
1
2

Reasons for withdrawal

Reasons for withdrawal
Measure
DLS 5.0 (Dynamic Locking Screws)
ORIF with DLS 5.0 (Dynamic Locking Screws) DLS 5.0 (Dynamic locking screws): Open reduction and internal fixation (ORIF) of the distal femur with a large fragment locking plate (LISS, LCP) and DLS 5.0
SLS (Standard Locking Screw)
ORIF with SLS (Standard locking screw) SLS (Standard locking screw): Open reduction and internal fixation (ORIF) of the distal femur with a large fragment locking plate (LISS, LCP)and SLS (Standard locking screw)
Overall Study
Withdrawal by Subject
1
1
Overall Study
Physician Decision
0
1

Baseline Characteristics

Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
DLS 5.0 (Dynamic Locking Screws)
n=2 Participants
ORIF with DLS 5.0 (Dynamic Locking Screws) DLS 5.0 (Dynamic locking screws): Open reduction and internal fixation (ORIF) of the distal femur with a large fragment locking plate (LISS, LCP) and DLS 5.0
SLS (Standard Locking Screw)
n=3 Participants
ORIF with SLS (Standard locking screw) SLS (Standard locking screw): Open reduction and internal fixation (ORIF) of the distal femur with a large fragment locking plate (LISS, LCP)and SLS (Standard locking screw)
Total
n=5 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Age, Categorical
>=65 years
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Age, Continuous
68.5 years
n=5 Participants
55 years
n=7 Participants
60.4 years
n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Region of Enrollment
Switzerland
0 participants
n=5 Participants
1 participants
n=7 Participants
1 participants
n=5 Participants
Region of Enrollment
Germany
2 participants
n=5 Participants
2 participants
n=7 Participants
4 participants
n=5 Participants

PRIMARY outcome

Timeframe: 12 months after surgery

Population: Five patients signed the informed consent form and were enrolled in the study before it was terminated. Three of the five patients were post-enrollment drop-outs and only two patients completed all study follow-up visits. No analysis was done. Due to the low number of patients an analysis was not indicated, therefore no results are available.

To assess pain, stiffness, and physical function

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 weeks ± 7 days, 6 months ± 30 days

Population: Five patients signed the informed consent form and were enrolled in the study before it was terminated. Three of the five patients were post-enrollment drop-outs and only two patients completed all study follow-up visits. No analysis was done. Due to the low number of patients an analysis was not indicated, therefore no results are available.

The TUG measures the time (in seconds) that it takes for an individual to rise from an armchair (chair seat height = 45 cm / 1.5 feet), walk 3 meters (= 10 feet) to a line drawn on the floor, turn around and return to the chair. The time is measured from a seated position (back against the backrest) with a stopwatch started on the command "ready - go" and stopped when the seated position is reached again.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Preoperative, 6 weeks ±7 days, 12 weeks ± 7 days, 6 months ± 30 days, 12 months up to 425 days after surgery

Population: Five patients signed the informed consent form and were enrolled in the study before it was terminated. Three of the five patients were post-enrollment drop-outs and only two patients completed all study follow-up visits. No analysis was done. Due to the low number of patients an analysis was not indicated, therefore no results are available.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 6 weeks ±7 days, 12 weeks ± 7 days, 6 months ± 30 days, 12 months up to 425 days after surgery

Population: Five patients signed the informed consent form and were enrolled in the study before it was terminated. Three of the five patients were post-enrollment drop-outs and only two patients completed all study follow-up visits. No analysis was done. Due to the low number of patients an analysis was not indicated, therefore no results are available.

Assessment of passive ROM of the knee (flexion - extension)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: weekly measurement at home

Population: Five patients signed the informed consent form and were enrolled in the study before it was terminated. Three of the five patients were post-enrollment drop-outs and only two patients completed all study follow-up visits. No analysis was done. Due to the low number of patients an analysis was not indicated, therefore no results are available.

Assessment of the timepoint when the patient : * can bear the whole body weight on the affected leg at single-leg-stance for 3 seconds * can walk without walking aid * has no intake of analgesics * has a pain level experienced at the fracture site during weight bearing over two consecutive measurements with a value of ≤ 3 as measured on a 0-10 numeric rating scale (NRS), where 0 = no pain and 10 = worst pain imaginable

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Preoperative, 6 weeks ±7 days, 12 weeks ± 7 days, 6 months ± 30 days, 12 months up to 425 days after surgery

Population: Five patients signed the informed consent form and were enrolled in the study before it was terminated. Three of the five patients were post-enrollment drop-outs and only two patients completed all study follow-up visits. No analysis was done. Due to the low number of patients an analysis was not indicated, therefore no results are available.

To assess pain, stiffness, and physical function

Outcome measures

Outcome data not reported

Adverse Events

DLS 5.0 (Dynamic Locking Screws)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

SLS (Standard Locking Screw)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Clinical Operations Manager of Clinical Investigation and Documentation

AO Foundation

Phone: 0041 44 200 24 67

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place